Cynata Therapeutics Statistics

Total Valuation

ASX:CYP has a market cap or net worth of AUD 77.36 million. The enterprise value is 72.31 million.

Market Cap	77.36M
Enterprise Value	72.31M

Important Dates

The next estimated earnings date is Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:CYP has 241.75 million shares outstanding. The number of shares has increased by 14.10% in one year.

Current Share Class	241.75M
Shares Outstanding	241.75M
Shares Change (YoY)	+14.10%
Shares Change (QoQ)	+22.37%
Owned by Insiders (%)	8.35%
Owned by Institutions (%)	13.43%
Float	187.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	41.04
PB Ratio	12.93
P/TBV Ratio	12.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.70
EV / Sales	38.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.40

Current Ratio	4.40
Quick Ratio	4.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -142.29% and return on invested capital (ROIC) is -91.02%.

Return on Equity (ROE)	-142.29%
Return on Assets (ROA)	-77.08%
Return on Invested Capital (ROIC)	-91.02%
Return on Capital Employed (ROCE)	-160.67%
Weighted Average Cost of Capital (WACC)	9.97%
Revenue Per Employee	942,570
Profits Per Employee	-4.70M
Employee Count	2
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.84% in the last 52 weeks. The beta is 1.04, so ASX:CYP's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	+48.84%
50-Day Moving Average	0.30
200-Day Moving Average	0.22
Relative Strength Index (RSI)	48.44
Average Volume (20 Days)	423,146

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:CYP had revenue of AUD 1.89 million and -9.39 million in losses. Loss per share was -0.05.

Revenue	1.89M
Gross Profit	1.89M
Operating Income	-9.61M
Pretax Income	-9.39M
Net Income	-9.39M
EBITDA	-9.33M
EBIT	-9.61M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 5.05 million in cash and n/a in debt, with a net cash position of 5.05 million or 0.02 per share.

Cash & Cash Equivalents	5.05M
Total Debt	n/a
Net Cash	5.05M
Net Cash Per Share	0.02
Equity (Book Value)	5.98M
Book Value Per Share	0.03
Working Capital	4.13M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.72M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-509.82%
Pretax Margin	-498.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:CYP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.10%
Shareholder Yield	-14.10%
Earnings Yield	-12.14%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 31, 2013. It was a reverse split with a ratio of 0.05.

Last Split Date	Oct 31, 2013
Split Type	Reverse
Split Ratio	0.05

Scores

ASX:CYP has an Altman Z-Score of 0.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.28
Piotroski F-Score	2